Pecanex 4, also known as PCNX4, is a lesser-known protein that is part of the pecanex family of proteins. The pecanex family is characterized by its role in fundamental cellular processes, although the specific functions of each member, including PCNX4, may vary and are not fully elucidated. However, it is thought that proteins in this family may be involved in Notch signaling, a highly conserved pathway that influences cell fate decisions, differentiation, proliferation, and apoptosis.Notch signaling is critical for proper embryonic development and tissue homeostasis, and pecanex proteins are believed to play a role in the regulation of this pathway at some level. Pecanex proteins may interact with components of the Notch signaling pathway or be involved in processes that are crucial for the pathway's function, such as trafficking of Notch receptors or ligands within the cell.
PCNX4, like its relatives, contains multiple transmembrane domains, suggesting a role in the endoplasmic reticulum or Golgi apparatus, where it may be involved in the trafficking of proteins or the regulation of secretory pathways. The endoplasmic reticulum and Golgi apparatus are key organelles in the synthesis, folding, modification, and transport of proteins, and pecanex proteins are thought to contribute to these processes, potentially ensuring proper protein folding and preventing the accumulation of misfolded proteins.While the precise biological functions of PCNX4 remain to be fully determined, its association with the pecanex family suggests that it may play a role in cellular processes that are critical for development and cell signaling. Research into PCNX4 and related proteins may reveal important insights into the molecular mechanisms underlying these fundamental cellular functions and how their dysregulation can contribute to disease states, including developmental disorders and cancer.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D inhibits RNA synthesis by binding to DNA, preventing RNA polymerase from elongating, thereby inhibiting the expression of C14orf135 at the transcriptional level. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits protein synthesis by blocking the translocation step in eukaryotic ribosomes, leading to reduced expression of C14orf135 by preventing the elongation of the nascent polypeptide chain. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Puromycin is an aminonucleoside antibiotic that causes premature chain termination during translation, thus leading to truncated protein products and potentially inhibiting the full expression of C14orf135. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is a pyrimidine analog that inhibits thymidylate synthase, disrupting DNA synthesis and interfering with the expression of C14orf135 due to the reduced availability of thymidine for DNA replication. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Tunicamycin inhibits N-linked glycosylation by blocking the formation of dolichol pyrophosphate, leading to the misfolding and degradation of glycoproteins, which may include C14orf135 if it undergoes N-linked glycosylation. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin inhibits bacterial RNA polymerase, potentially affecting the transcription of genes, including C14orf135, in bacterial expression systems. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide inhibits RNA polymerase I, II, and III, leading to reduced expression of various genes, potentially including C14orf135, which is transcriptionally regulated by RNA polymerase II. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine intercalates into DNA and inhibits topoisomerase II, leading to reduced gene transcription, potentially affecting the expression of C14orf135 due to decreased RNA polymerase activity. | ||||||
Ethidium bromide | 1239-45-8 | sc-203735 sc-203735A sc-203735B sc-203735C | 1 g 5 g 25 g 100 g | $48.00 $150.00 $588.00 $2086.00 | 12 | |
Ethidium bromide intercalates into DNA, leading to the inhibition of DNA replication and gene transcription, potentially affecting the expression of C14orf135 by interfering with the transcription of its encoding gene. | ||||||